Trial Identifier: | D5130C00161 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02615704 |
Start Date: | February 2016 |
Primary Completion Date: | March 2019 |
Study Completion Date: | March 2019 |
Condition: | Coronary Artery Disease |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Germany | Bad Berka, Germany, 99437 |
Germany | Bad Bevensen, Germany, 29549 |
Germany | Bad Krozingen, Germany, 79189 |
Germany | Barby, Germany, 39249 |
Germany | Berlin, Germany, D-13353 |
Germany | Berlin, Germany, 10117 |
Germany | Berlin, Germany, 12203 |
Germany | Berlin-Tegel, Germany, 13507 |
Germany | Bernau, Germany, 16321 |
Germany | Chemnitz, Germany, 09116 |
Germany | Coburg, Germany, 96450 |
Germany | Düsseldorf, Germany, 40217 |
Germany | Düsseldorf, Germany, 40210 |
Germany | Erkrath, Germany, 40699 |
Germany | Essen, Germany, 45219 |
Germany | Flechtingen, Germany, 39345 |
Germany | Frankfurt, Germany, 65929 |
Germany | Fulda, Germany, 36037 |
Germany | Gelsenkirchen, Germany, 45891 |
Germany | Hamburg, Germany, 20099 |
Germany | Heidelberg, Germany, 69120 |
Germany | Kassel, Germany, 34121 |
Germany | Kassel, Germany, 34117 |
Germany | Kiel, Germany, 24105 |
Germany | Kleve, Germany, 47533 |
Germany | Köln, Germany, 51109 |
Germany | Lübeck, Germany, 23560 |
Germany | Mainz, Germany, 55131 |
Germany | Mönchengladbach, Germany, 41063 |
Germany | Münster, Germany, 48149 |
Germany | Oldenburg, Germany, 26133 |
Germany | Regensburg, Germany, 93053 |
Germany | Rostock, Germany, 18057 |
Germany | Rotenburg, Germany, 36199 |
Germany | Siegen, Germany, 57072 |
Germany | Wuppertal, Germany, 42117 |